222 related articles for article (PubMed ID: 21519213)
1. Chronic renal allograft damage: existing challenges.
Arias M; Serón D; Moreso F; Bestard O; Praga M
Transplantation; 2011 May; 91(9 Suppl):S4-25. PubMed ID: 21519213
[No Abstract] [Full Text] [Related]
2. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
Nashan B
Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
[TBL] [Abstract][Full Text] [Related]
3. [Renal transplant and chronic rejection in pediatrics].
Cano FJ
Rev Med Chil; 1998 Jan; 126(1):96-106. PubMed ID: 9629760
[TBL] [Abstract][Full Text] [Related]
4. [From acute to chronic rejection after kidney transplantation].
Arns W; Weber M
Med Klin (Munich); 2002 Oct; 97(10):609-13. PubMed ID: 12386794
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
6. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
7. [The mechanisms of chronic kidney damage in renal transplant and their possible reversibility].
Schena FP; Maiorano A; Rossini M
G Ital Nefrol; 2008; 25 Suppl 44():S11-4. PubMed ID: 19048580
[TBL] [Abstract][Full Text] [Related]
8. [Cyclosporin in transplantation management--especially after kidney transplantation].
Quellhorst E
Internist (Berl); 1996 Jan; 37(1):88-90. PubMed ID: 8837834
[No Abstract] [Full Text] [Related]
9. In vivo immunosuppressive effect of purine nucleoside phosphorylase inhibitor-8-amino-9-benzyl-guanine in canine renal allograft rejection.
Lin CY; Yen CY
Transplant Proc; 1994 Dec; 26(6):3126-7. PubMed ID: 7998091
[No Abstract] [Full Text] [Related]
10. New concepts to individualize calcineurin inhibitor therapy in renal allograft recipients.
Sommerer C; Giese T; Meuer S; Zeier M
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1030-7. PubMed ID: 21060169
[TBL] [Abstract][Full Text] [Related]
11. Chronic rejection of renal allografts with four immunosuppressive regimens.
Isoniemi H; Ahonen J; Krogerus L; Eklund B; Höckerstedt K; Salmela K; Häyry P
Transplant Proc; 1992 Dec; 24(6):2716-7. PubMed ID: 1465912
[No Abstract] [Full Text] [Related]
12. [Immunosuppression in the kidney transplant. Old drugs and new acquisitions].
Rodríguez Ferrero M; Valderrábano F
Rev Clin Esp; 1997 Oct; 197(10):703-12. PubMed ID: 9424669
[No Abstract] [Full Text] [Related]
13. Calcineurin inhibitor-free immunosuppression in kidney transplantation.
Guerra G; Srinivas TR; Meier-Kriesche HU
Transpl Int; 2007 Oct; 20(10):813-27. PubMed ID: 17645419
[TBL] [Abstract][Full Text] [Related]
14. Ten-year protocol biopsy findings of renal allografts in the calcineurin inhibitor era.
Okamoto M; Akioka K; Ushigome H; Higuchi A; Nobori S; Ogino S; Uryuhara K; Kaihara S; Hatta T; Urasaki K; Yoshimura N
Clin Transplant; 2006; 20 Suppl 15():16-9. PubMed ID: 16848870
[TBL] [Abstract][Full Text] [Related]
15. [Future problems for the further improvement of long renal graft survival].
Morozumi K; Takeda A; Uchida K
Nihon Jinzo Gakkai Shi; 2005; 47(5):508-16. PubMed ID: 16130405
[No Abstract] [Full Text] [Related]
16. Transplantation: new protocols and new worries.
Grinyo JM
Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):192-7. PubMed ID: 19237802
[No Abstract] [Full Text] [Related]
17. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
Wali RK; Weir MR
Curr Opin Organ Transplant; 2008 Dec; 13(6):614-21. PubMed ID: 19060552
[TBL] [Abstract][Full Text] [Related]
18. Prolonged renal allograft survival in chronic rejection by conversion to triple therapy.
Beckingham IJ; Dennis MJ; Innes A; Burden RP; Morgan AG; Bishop MC
Transplant Proc; 1993 Apr; 25(2):2100. PubMed ID: 8470283
[No Abstract] [Full Text] [Related]
19. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
[TBL] [Abstract][Full Text] [Related]
20. [Nephrology--Part 2. Strategies in the immunosuppression after kidney transplantation].
Sperschneider H; Heemann U; Stein G
Med Klin (Munich); 2003 Mar; 98(3):140-5. PubMed ID: 12647088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
